









Märkte
/
Aktien
/
nasdaq-elv
/

Elevance Health Inc

ELV

317.220USD

-4.730-1.47%

Handelsschluss 10/31, 16:00（ET）Kurse um 15 Minuten verzögert

70.43BMarktkapitalisierung

12.73KGV TTM



Elevance Health Inc

317.220

-4.730-1.47%

Übersicht Unternehmen Finanzen Analyse

Übersicht

Unternehmen

Finanzen

Analyse

mehr Informationen über Elevance Health Inc Unternehmen

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.

Elevance Health Inc Informationen



BörsenkürzelELV

Name des UnternehmensElevance Health Inc

IPO-datumOct 30, 2001

CEOMs. Gail K. Boudreaux

Anzahl der mitarbeiter103158

WertpapierartOrdinary Share

GeschäftsjahresendeOct 30

Addresse220 Virginia Avenue

StadtINDIANAPOLIS

BörseNYSE Consolidated

LandUnited States of America

Postleitzahl46204

Telefon18003311476

Websitehttps://www.elevancehealth.com/

BörsenkürzelELV

IPO-datumOct 30, 2001

CEOMs. Gail K. Boudreaux

Führungskräfte von Elevance Health Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Ramiro G. Peru

Independent Chairman of the Board

9.35K

+6.87%

Mr. Antonio F. Neri

Independent Director

4.92K

+13.90%

Dr. Bahija Jallal, Ph.D.

Independent Director

4.79K

+14.35%

Mr. Ronald W. Penczek

Chief Accounting Officer, Controller

1.69K

+3.99%

Ms. Deanna D. Strable-Soethout

Independent Director

1.65K

+57.51%

Mr. Steven H. (Steve) Collis, CPA

Independent Director

639.00

Mr. Robert L. Dixon, Jr.

Independent Director

Mr. Mark B. Kaye

Chief Financial Officer, Executive Vice President

Mr. Ratnakar V. Lavu

Executive Vice President and Chief Digital Information Officer

Ms. Gail K. Boudreaux

President, Chief Executive Officer, Director

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Ramiro G. Peru

Independent Chairman of the Board

9.35K

+6.87%

Mr. Antonio F. Neri

Independent Director

4.92K

+13.90%

Dr. Bahija Jallal, Ph.D.

Independent Director

4.79K

+14.35%

Mr. Ronald W. Penczek

Chief Accounting Officer, Controller

1.69K

+3.99%

Ms. Deanna D. Strable-Soethout

Independent Director

1.65K

+57.51%

Mr. Steven H. (Steve) Collis, CPA

Independent Director

639.00

Umsatzaufteilung

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Premiums

41.27B

0.00%

Product revenue

6.04B

0.00%

Service fees

2.11B

0.00%

Reconciliation

355.00M

0.00%

Operating revenue - affliated

0.00

0.00%

Keine Daten

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Premiums

41.27B

0.00%

Product revenue

6.04B

0.00%

Service fees

2.11B

0.00%

Reconciliation

355.00M

0.00%

Operating revenue - affliated

0.00

0.00%

Aktionärsstatistik

Aktualisiert: Sun, Oct 26

Aktionäre

Aktionärstypen

Aktionäre

Anteil

The Vanguard Group, Inc.

10.24%

BlackRock Institutional Trust Company, N.A.

5.23%

State Street Investment Management (US)

4.76%

T. Rowe Price Associates, Inc.

3.49%

Capital International Investors

2.92%

Andere

73.37%

Aktionäre

Anteil

The Vanguard Group, Inc.

10.24%

BlackRock Institutional Trust Company, N.A.

5.23%

State Street Investment Management (US)

4.76%

T. Rowe Price Associates, Inc.

3.49%

Capital International Investors

2.92%

Andere

73.37%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

52.91%

Investment Advisor/Hedge Fund

31.90%

Bank and Trust

2.47%

Pension Fund

2.44%

Research Firm

2.01%

Hedge Fund

1.73%

Sovereign Wealth Fund

1.42%

Family Office

0.27%

Family Office

0.27%

Andere

4.59%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

3047

209.27M

92.93%

-7.67M

2025Q2

3093

215.32M

95.62%

-4.57M

2025Q1

3135

209.98M

92.91%

-9.57M

2024Q4

3098

213.30M

93.78%

-5.08M

2024Q3

3004

212.78M

91.75%

-6.27M

2024Q2

2973

214.50M

92.28%

-4.31M

2024Q1

2940

212.64M

91.38%

-6.83M

2023Q4

2879

214.42M

91.26%

-6.60M

2023Q3

2767

215.95M

91.62%

-5.63M

2023Q2

2750

218.40M

92.12%

-4.32M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

22.75M

10.1%

-140.75K

-0.61%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

11.62M

5.16%

-183.35K

-1.55%

Jun 30, 2025

State Street Investment Management (US)

10.57M

4.69%

-78.72K

-0.74%

Jun 30, 2025

T. Rowe Price Associates, Inc.

7.75M

3.44%

-1.01M

-11.48%

Jun 30, 2025

Capital International Investors

6.49M

2.88%

+932.14K

+16.78%

Jun 30, 2025

Wellington Management Company, LLP

6.32M

2.81%

+523.40K

+9.03%

Jun 30, 2025

Sanders Capital, LLC

5.83M

2.59%

+1.15M

+24.66%

Jun 30, 2025

Geode Capital Management, L.L.C.

5.09M

2.26%

-72.83K

-1.41%

Jun 30, 2025

Artisan Partners Limited Partnership

3.68M

1.63%

+324.40K

+9.68%

Jun 30, 2025

First Eagle Investment Management, L.L.C.

3.20M

1.42%

-41.22K

-1.27%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Mon, Oct 6

Name

Anteil

iShares U.S. Healthcare Providers ETF

9.06%

Monarch Dividend Plus Index ETF

3.38%

GMO US Quality ETF

2.36%

First Trust Total US Market AlphaDEX ETF

2.2%

Monarch Volume Factor Dividend Tree Index ETF

2.17%

T Rowe Price Equity Income ETF

1.88%

John Hancock Fundamental All Cap Core ETF

1.84%

iShares Large Cap Value Active ETF

1.71%

VictoryShares Free Cash Flow ETF

1.64%

Bushido Capital US Equity ETF

1.63%

iShares U.S. Healthcare Providers ETF

Anteil9.06%

Monarch Dividend Plus Index ETF

Anteil3.38%

GMO US Quality ETF

Anteil2.36%

First Trust Total US Market AlphaDEX ETF

Anteil2.2%

Monarch Volume Factor Dividend Tree Index ETF

Anteil2.17%

T Rowe Price Equity Income ETF

Anteil1.88%

John Hancock Fundamental All Cap Core ETF

Anteil1.84%

iShares Large Cap Value Active ETF

Anteil1.71%

VictoryShares Free Cash Flow ETF

Anteil1.64%

Bushido Capital US Equity ETF

Anteil1.63%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 6.19B USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Jan 23, 2025

ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025

Mar 10, 2025

Mar 25, 2025

Mar 10, 2025

Oct 17, 2024

ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024

Dec 05, 2024

Dec 20, 2024

Dec 05, 2024

Jul 17, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024

Sep 10, 2024

Sep 25, 2024

Sep 10, 2024

Apr 18, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024

Jun 10, 2024

Jun 25, 2024

Jun 10, 2024

Jan 26, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024

Mar 08, 2024

Mar 22, 2024

Mar 07, 2024

Oct 18, 2023

ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 19, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023

Sep 08, 2023

Sep 22, 2023

Sep 07, 2023

Apr 19, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023

Jun 09, 2023

Jun 23, 2023

Jun 08, 2023

Jan 25, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023

Mar 10, 2023

Mar 24, 2023

Mar 09, 2023

Oct 19, 2022

ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022

Dec 05, 2022

Dec 21, 2022

Dec 02, 2022

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

KeyAI

